Differential effects of estrogen and progesterone on potassium channels expressed in Xenopus oocytes

Steroids

Volumn 73, Issue 3, 2008, Pages 272-279

  Wong, Chi Ming ^a,b   Tsang, Suk Ying ^a   Yao, Xiaoqiang ^a   Chan, Franky Leung ^a   Huang, Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

17 estradiol; Potassium channel expression; Progesterone; Xenopus oocytes

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYCLOHEXIMIDE; DACTINOMYCIN; ESTROGEN; FULVESTRANT; IBERIOTOXIN; POTASSIUM CHANNEL; PROGESTERONE; TAMOXIFEN; TETRYLAMMONIUM;

ARTICLE; CONJUGATION; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PROTEIN EXPRESSION; VOLTAGE CLAMP;

ANIMALS; ESTRADIOL; ESTROGENS; HUMANS; KV1.5 POTASSIUM CHANNEL; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MOLECULAR SEQUENCE DATA; OOCYTES; PATCH-CLAMP TECHNIQUES; PROGESTERONE; PROGESTINS; XENOPUS LAEVIS;

EID: 38649136234     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.10.010     Document Type: Article

References (34)

1. Jiang F., Sarrel P.M., Lindsey D.C., Poole-Wilson P.A., and Colins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 104 (1991) 1033-1037
2. Gorodeski G.I., Yang T., Levy M.N., Goldfarb J., and Utian W.H. Modulation of coronary vascular resistance in female rabbits by estrogen and progesterone. J Soc Gynecol Investig 5 (1998) 197-202
3. + channels in coronary vasodilation induced by 17β-estradiol in ischemic heart failure. FASEB J 11 (1997) 793-799
4. Bell D.R., Rensberger H.J., Koritnik D.R., and Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol Heart Circ Physiol 268 (1995) H377-H383
5. Mendelson M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
6. Ca channels through cGMP-dependent mechanism. Circ Res 77 (1995) 936-942
7. + channels to relaxation induced by 17β-estradiol but not by progesterone in isolated rat mesenteric artery rings. J Cardiovasc Pharmacol 41 (2003) 4-13
8. + channels. Circ Res 79 (1996) 1024-1030
9. Darkow D.J., Lu L., and White R.E. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP. Am J Physiol Cell Physiol 272 (1997) H2765-H2773
10. Valverde M.A., Rojas P., Amigo J., Cosmelli D., Orio P., Bahamonde M.I., et al. Acute activation of Maxi-K channels (hslo) by estradiol binding to the beta subunit. Science 285 (1999) 1929-1931
11. Dick G.M., and Sanders K.M. (Xeno)estrogen sensitivity of smooth muscle BK channels conferred by the regulatory (1 subunit: a study of (1 knockout mice. J Biol Chem 276 (2001) 44835-44840
12. Duncan R.K. Tamoxifen alters gating of the BK alpha subunit and mediates enhanced interactions with the avian beta subunit. Biochem Pharmacol 70 (2005) 47-58
13. Chambliss K.L., Yuhanna I.S., Mineo C., Liu P., German Z., Sherman T.S., et al. Estrogen receptor α and endothelial nitric oxide synthase are originized into a functional signaling module in caveolae. Circ Res 87 (2000) e44-e52
14. Ho K.J., and Liao J.K. Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease. Mol Intervent 2 (2002) 219-228
15. Russell K.S., Haynes M.P., Sinha D., Clerisme E., and Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97 (2000) 5930-5935
16. Nelson M.T., and Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268 (1995) C799-C822
17. Chan H.Y., Yao X.Q., Tsang S.Y., Chan F.L., Lau C.W., and Huang Y. Different role of endothelium/nitric oxide in 17ß-estradiol and progesterone-induced relaxation in rat arteries. Life Sci 69 (2001) 1609-1617
18. Fuller P.J. The steroid receptor superfamily: mechanisms of diversity. FASEB J 5 (1991) 3092-3099
19. Sadler S.E., and Maller J.L. Identification of a steroid receptor on the surface of Xenopus oocytes by photoaffinity labeling. J Biol Chem 257 (1982) 355-361
20. Morrill G.A., and Kostellow A.B. Calcium and cell function. 6th ed. (1986), Academic Press, New York pp. 209-52
21. Maller J.L., Brutcher F.R., and Krebs E.G. Early effect of progesterone on levels of cyclic adenosine 3′:5′-monophosphate in Xenopus oocytes. J Biol Chem 254 (1979) 579-582
22. Sadler S.E., and Maller J.L. Inhibition of Xenopus laevis adenylate cyclase by progesterone: a novel mechanism of action. Adv Cyclic Nucleotide Protein Phosphorylation Res 19 (1985) 179-194
23. Colditz G.A., Hankinson S.E., Hunter D.J., Willett W.C., Manson J.E., Stampfer M.J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332 (1995) 1589-1593
24. Southcott B.M. CarCinoma of the endometrium. Drugs 61 (2001) 1395-1405
25. Wagner J.D. Rationale for hormone replacement therapy in atherosclerosis prevention. J Reprod Med 45 (2000) 245-258
26. Cano A. Progestins and coronary heart disease. Hum Reprod Update 5 (1999) 189-190
27. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., and Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol 211 (1992) 163-167
28. Omar H.A., Ramirez R., and Gibson M. Properties of a progesterone-induced relaxation in human placental arteries and veins. J Clin Endocrinol Metab 80 (1995) 370-373
29. Barbagallo M., Dominguez L.J., Licata G., Shan J., Bing L., Karpinski E., et al. Vascular effects of progesterone: role of cellular calcium regulation. Hypertension 37 (2001) 142-147
30. Sarrel P.M. The differential effects of oestrogens and progestins on vascular tone. Hum Reprod Update 5 (1999) 205-209
31. Millar V.M., and Vanhoutte P.M. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol Regulatory Integrative Comp Physiol 261 (1991) R1022-R1027
32. Hanke H., Hanke S., Bruck B., Brehme U., Gugel N., Finking G., et al. Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis 121 (1996) 129-138
33. Teoh H., and Man R.Y. Progesterone modulates estradiol actions: acute effects at physiological concentrations. Eur J Pharmacol 378 (1999) 57-62
34. 2+ channel gene expression by chronic treatment with estrogen and tamoxifen in rat aorta. Eur J Pharmacol 483 (2004) 155-162